Michael J. Farrell Resmed Inc (RSMDF) insider trading activity

Michael J. Farrell is Chairman and CEO of RESMED INC. Currently has a direct ownership of 466,223 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Nov 16, 2021, when has been sold 71,262 shares (ResMed Common Stock) at a price of $254.81 per share, resulting in proceeds of $18,158,270. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 466K

0.34% 3M change

2.36% 12M change

Total Value Held $0

Michael J. Farrell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 16 2021	BUY Grant, award, or other acquisition	$18,158,270 $254.81 p/Share	71,262 Added 12.76%	487,220 ResMed Common Stock
Nov 11 2021	SELL Payment of exercise price or tax liability	$2,269,844 $259.47 p/Share	8,748 Reduced 2.06%	415,958 ResMed Common Stock
Aug 19 2021	BUY Grant, award, or other acquisition	-	18,418 Added 4.16%	424,611 ResMed Common Stock
Jan 18 2021	BUY Grant, award, or other acquisition	-	7,014 Added 1.7%	406,160 ResMed Common Stock
Nov 17 2020	SELL Payment of exercise price or tax liability	$10,688,899 $214.74 p/Share	49,776 Reduced 11.09%	399,146 ResMed Common Stock
Nov 17 2020	BUY Grant, award, or other acquisition	$19,162,969 $214.74 p/Share	89,238 Added 16.58%	448,922 ResMed Common Stock
Nov 11 2020	SELL Payment of exercise price or tax liability	$1,826,479 $212.11 p/Share	8,611 Reduced 2.34%	359,684 ResMed Common Stock

Also insider at

ZBH

ZIMMER BIOMET HOLDINGS, INC. Healthcare

MJF